BIOMERICA INC
BMRAStock
$1.63−46.20%52W
Market Cap$5.13M
P/E—
Div yield—
Beta0.33
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-47.63%
Price vs S&P 500 (4W)-18.10%
VGM Score44.25
Market Capitalization$5.13M
Earnings Surprise History
Q3 26-0.44est. —
Analyst Recommendations
Apr 2022
May 2022
Jun 2022
Jul 2022
4.29
4.29
4.29
4.29
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BMRABIOMERICA INC | B | D | D | $1.63 |
| IDXXIdexx Laboratories Inc | D | B | C | $576.07 |
| LNTHLantheus Holdings, Inc | C | B | B | $105.11 |
| CLDXCelldex Therapeutics, Inc | F | F | B | $35.40 |
| NEOGNeogen Corp | C | C | B | $10.33 |
| NTLAIntellia Therapeutics, Inc | D | C | C | $11.86 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | B | F | $9.60 |
| QDELQuidelOrtho Corporation Common Stock | C | C | C | $18.24 |
| ACHVAchieve Life Sciences, Inc. | F | F | A | $5.96 |
| MYGNMyriad Genetics Inc | C | C | B | $6.19 |
| TKNOAlpha Teknova, Inc. Common Stock | C | C | B | $5.32 |
About
Biomerica develops and markets medical diagnostic products for early detection and monitoring of chronic diseases, with a focus on gastrointestinal conditions, food intolerances, and diabetes. The company generates the majority of its revenue from Asia while maintaining a global presence across Europe, North America, the Middle East, and South America.